SynthesisFrontiers in medicine2025
Ferroptosis research based on bibliometric and visual analysis: mechanism exploration and clinical application prospects in gastric cancer, prostate cancer, leukemia, and brain tumors.
Synthesis in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Global evolution of ferroptosis research: a comprehensive bibliometric analysis of publication trends, geographic patterns, pharmacological innovation, and translational progress from inception through 2025.Naunyn-Schmiedeberg's archives of pharmacology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Ferroptosis, iron-dependent cell death, holds significant therapeutic potential in oncology. This study aimed to map global research trends (2014-2024) of ferroptosis in gastric cancer, prostate cancer, leukemia, and brain tumors via bibliometric analysis, identifying key developments and clinical prospects. Methods: Publications from Web of Science, Scopus, and PubMed were analyzed using VOSviewer, CiteSpace for output, collaborations, influential authors/works (co-citation), and keyword trends (burst detection). Results: Research output surged, led by China and the USA. Foundational authors (Dixon, Yang, Stockwell) were highly co-cited. Emerging hotspots include overcoming therapy resistance, tumor microenvironment modulation, immunotherapy integration, and nanotechnology applications. Cancer-specific foci like GPx4 (gastric) and p53 (prostate) pathways were evident. Conclusion: This analysis provides a comprehensive map of the evolving ferroptosis research landscape across these four cancers, revealing a distinct shift towards translational applications. The findings of this study provide a valuable framework for guiding future research and for the prioritization of clinical strategies targeting ferroptosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.